EMBC
Embecta Corp. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2025-11-25
Figures on this page computed 2026-11-08 12:24 UTC
Last close
6.52USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2025-11-25
3.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
- computed
- 10-K for 2025, filed 2025-11-25
29.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
8.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
16.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
5.2%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2025-11-25
Growth is the furthest below its sector's middle: 0.28 against 0.47 on the market's range.
Then and now
lens 3 of 9| Fact | 2020 | 2025 | Change |
|---|---|---|---|
| Sales | 1,085,500,000 | 1,080,400,000 | -0.5% |
| Profit | 427,600,000 | 95,400,000 | -77.7% |
| Free cash flow | 456,600,000 | 182,400,000 | -60.1% |
| Debt | n/a | 1,447,400,000 | n/a |
| Shares in issue | 57,013,000 | 58,915,000 | +3.3% |
The same five facts for 2020 and 2025, each read from the year's own filing.
The same five facts for 2020 and 2025, each read from the year's own filing.
Every figure in this lens
Except where said otherwise: 10-K for 2020, filed 2022-12-22
Sales, 20201,085,500,000
- Source
- filed
- Statement
- income
- Fiscal year
- 2020
- Accession
- 0001872789-22-000024
- Reported in
- USD
Sales, 20251,080,400,00010-K for 2025, filed 2025-11-25
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
Profit, 2020427,600,000
- Source
- filed
- Statement
- income
- Fiscal year
- 2020
- Accession
- 0001872789-22-000024
- Reported in
- USD
Profit, 202595,400,00010-K for 2025, filed 2025-11-25
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
Free cash flow, 2020456,600,000
- Source
- filed
- Statement
- income
- Fiscal year
- 2020
- Accession
- 0001872789-22-000024
- Reported in
- USD
Free cash flow, 2025182,400,00010-K for 2025, filed 2025-11-25
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
Debt, 2020n/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2020
- Accession
- 0001872789-22-000024
- Reported in
- USD
Debt, 20251,447,400,00010-K for 2025, filed 2025-11-25
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD
Shares in issue, 202057,013,000
- Source
- filed
- Statement
- income
- Fiscal year
- 2020
- Accession
- 0001872789-22-000024
- Reported in
- USD
Shares in issue, 202558,915,00010-K for 2025, filed 2025-11-25
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001872789-25-000036
- Reported in
- USD